Your email has been successfully added to our mailing list.

×
0 -0.00125886930647744 0.00114442664225223 -0.0010299839780269 -0.00423437857633317 -0.00423437857633317 0.00972762645914404 0.00549324788281074
Stock impact report

Amarin Applauds HealthyWomen's Citizen's Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event [Yahoo! Finance]

Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share (AMRN) 
Last amarin corporation plc - american depositary shares, each representing one ordinary share earnings: 4/30 05:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.amarincorp.com/investors
Company Research Source: Yahoo! Finance
DUBLIN, Ireland and BRIDGEWATER, N.J., April 24, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced its support for a petition filed with the U.S. Food and Drug Administration (FDA) requesting that the Commissioner focus on and take further action to address significant off-label prescribing of fenofibrates, due to the fact that multiple clinical trials have proven fenofibrates have no clinical benefit when used in combination with statins to reduce cardiovascular disease (CVD) risk. The filing comes as heart disease continues to be the leading cause of death in the United States, accounting for one in five deaths in 2021. Approximately 805,000 people in the United States have a heart attack each year, which amounts to one person every 40 seconds. The annual treatment cost for CVD is $555 billion, which is expected to double within 20 years. Despite the FDA mandating label changes in 2015 for fenofibrates, more than 11 million prescriptions were written a Show less Read more
Impact Snapshot
Event Time:
AMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AMRN alerts
Opt-in for
AMRN alerts

from News Quantified
Opt-in for
AMRN alerts

from News Quantified